Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection?
Luong
M-L
ML
Department of Medicine, Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15261, USA.
Sareyyupoglu
B
B
Nguyen
M H
MH
Silveira
F P
FP
Shields
R K
RK
Potoski
B A
BA
Pasculle
W A
WA
Clancy
C J
CJ
Toyoda
Y
Y
D016724:Empyema, Pleural / Q000453:epidemiology / Q000382:microbiology*; D016908:Gram-Positive Bacterial Infections / Q000453:epidemiology / Q000382:microbiology*; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D052201:Lacticaseibacillus rhamnosus / Q000145:classification / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity*; D016040:Lung Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D019936:Probiotics / Q000627:therapeutic use*; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D017422:Sequence Analysis, DNA
D012336:RNA, Ribosomal, 16S